Physician profile
Douglas Schechter
NPI 1588963888
$12,339.87
in general payments reported to CMS, 2019-2025
57 companies · $1,869 in 2025
The $1,869 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $1,344 · 2021: $2,028 · 2022: $1,581 · 2023: $2,008 · 2024: $2,322 · 2025: $1,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,198.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,060.35 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Abbott Laboratories | $2,023.69 | 2019-2025 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $1,133.02 | 2019-2025 | Ztlido |
| Vertos Medical, INC. | $826.76 | 2019-2023 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $683.60 | 2022-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $449.38 | 2019-2023 | Relistor |
| Boston Scientific Corporation | $434.21 | 2019-2024 | Intracept |
| Vertex Pharmaceuticals Incorporated | $358.63 | 2024-2025 | |
| Medtronic, INC. | $326.60 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Azurity Pharmaceuticals, INC. | $325.31 | 2023-2025 | Horizant, Horizant |
| Biodelivery Sciences International, INC. | $308.23 | 2019-2021 | |
| Allergan, INC. | $278.80 | 2019-2021 | |
| Nevro Corp. | $247.06 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $207.48 | 2019-2022 | |
| Protega Pharmaceutials INC | $154.19 | 2024-2025 | Roxybond |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $152.20 | 2023-2025 | Movantik |
| Almatica Pharma LLC | $143.75 | 2021-2023 | Gralise |
| Takeda Pharmaceuticals U.S.A., INC. | $138.52 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $131.80 | 2019-2020 | |
| Redhill Biopharma INC. | $130.53 | 2020-2022 | |
| Pfizer INC. | $126.12 | 2019-2025 | |
| Lundbeck LLC | $124.08 | 2023-2025 | Vyepti |
| Novo Nordisk INC | $120.00 | 2025 | Wegovy |
| Biohaven Pharmaceuticals, INC. | $116.02 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $112.30 | 2019-2024 | Caldolor, Kristalose |
| Virtus Pharmaceuticals LLC | $104.00 | 2021-2023 | Levorphanol Tartrate |
| Mml US, INC. | $102.42 | 2025 | Reactiv8 |
| Medtronic USA, INC. | $78.11 | 2019-2020 | |
| Forte Bio-Pharma LLC | $72.19 | 2025 | Prolate, Tanlor, Nalocet |
| Avanos Medical | $69.17 | 2019-2025 | Standard Rf Disposables |
| Biohaven Pharmaceutical Holding Company LTD. | $65.76 | 2022 | |
| Depuy Synthes Sales INC. | $62.20 | 2023-2024 | Orthovisc, Monovisc |
| Painteq LLC | $58.43 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $51.74 | 2020-2021 | |
| Stryker Corporation | $43.42 | 2025 | Mild Device Kit |
| Biotronik Nro, INC. | $42.74 | 2025 | Prospera |
| Horizon Therapeutics Plc | $39.29 | 2019-2022 | |
| Bioventus LLC | $38.86 | 2023-2024 | Gelsyn-3, Supartz Fx Sodium Hyaluronate |
| Relievant Medsystems, INC. | $33.32 | 2021-2022 | |
| Zyla Life Sciences, INC. | $33.00 | 2019 | |
| Shionogi INC | $32.32 | 2019 | |
| Hikma Pharmaceuticals USA | $31.61 | 2024 | Kloxxado |
| Assertio Therapeutics, INC. | $27.95 | 2019 | |
| Averitas Pharma INC. | $22.39 | 2024 | Qutenza |
| Ferring Pharmaceuticals INC. | $22.29 | 2025 | Euflexxa |
| Si-Bone, INC. | $21.57 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.39 | 2024 | Iovera, Zilretta |
| Kowa Pharmaceuticals America, INC. | $18.33 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $17.31 | 2024 | Dysport |
| Saluda Medical Americas, INC. | $16.90 | 2024 | Evoke |
| Lilly USA, LLC | $16.81 | 2022 | |
| Vertical Pharmaceuticals, LLC | $16.55 | 2019 | |
| Ibsa Pharma INC. | $15.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2020 | |
| Grt US Holding, INC. | $13.37 | 2021 | |
| Amgen INC. | $13.23 | 2019 | |
| Daiichi Sankyo INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Schechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.